胼胝体受累:鉴别法布里病与多发性硬化的有用线索
多中心回顾性研究评估104例法布里病与117例多发性硬化患者的FLAIR图像,法布里病组胼胝体白质病灶发生率仅2.9%,多发性硬化组达90.6%,提示胼胝体受累可作为两者鉴别的影像学征象。
要点
- 法布里病患者胼胝体病灶发生率极低(3/104,2.9%),多发性硬化患者高达90.6%(106/117)。
- 法布里病有神经系统症状亚组胼胝体病灶仅2/37(5.4%),仍远低于多发性硬化。
- 胼胝体有无病灶有助于将法布里病与多发性硬化快速区分。
核心结论
- 法布里病患者常规MR图像上胼胝体受累发生率远低于多发性硬化,且与临床表现及白质受累总体程度无关。
- 评估脑MR扫描上胼胝体病灶的有无可作为鉴别多发性硬化与法布里病的影像学征象,帮助医生快速指向正确诊断及后续治疗选择。
研究设计与样本
- 多中心回顾性研究,纳入104例法布里病患者与117例多发性硬化患者,评估FLAIR图像上白质病灶及胼胝体白质病灶的发生率。
- 另设37例有神经系统症状的法布里病亚组进行分析;以临床诊断分组作为参照。
关键影像表现/征象
- 法布里病组50/104例(48.1%)检出白质病灶,多发性硬化组全部患者均检出白质病灶。
- 法布里病组仅3/104例(2.9%)检出胼胝体病灶,多发性硬化组106/117例(90.6%)检出胼胝体病灶。
- 有神经系统症状的法布里病亚组中26/37例(70.3%)检出白质病灶,仅2/37例(5.4%)见明确的胼胝体病灶。
诊断标准与关键数值
- 法布里病组胼胝体白质病灶发生率2.9%(3/104),多发性硬化组90.6%(106/117)。
- 有神经系统症状的法布里病亚组胼胝体病灶发生率5.4%(2/37),白质病灶发生率70.3%(26/37)。
临床应用与阅片要点
- 阅片时若白质病灶患者胼胝体未见明确病灶,应想到法布里病可能,并与多发性硬化鉴别。
- 胼胝体病灶的存在更支持多发性硬化;法布里病胼胝体受累罕见,且不随临床表现或白质受累程度而增多。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Multiple sclerosis (MS) has been proposed as a possible differential diagnosis for Fabry disease (FD). The aim of this work was to evaluate the involvement of corpus callosum (CC) on MR images and its possible role as a radiological sign to differentiate between FD and MS.
METHODS: In this multicentric study, we retrospectively evaluated the presence of white matter lesions (WMLs) on the FLAIR images of 104 patients with FD and 117 patients with MS. The incidence of CC-WML was assessed in the two groups and also in a subgroup of 37 FD patients showing neurological symptoms.
RESULTS: WMLs were detected in 50 of 104 FD patients (48.1%) and in all MS patients. However, a lesion in the CC was detected in only 3 FD patients (2.9%) and in 106 MS patients (90.6%). In the FD subgroup with neurological symptoms, WMLs were present in 26 of 37 patients (70.3%), with two subjects (5.4%) showing a definite callosal lesion.
CONCLUSION: FD patients have a very low incidence of CC involvement on conventional MR images compared to MS, independently from the clinical presentation and the overall degree of WM involvement. Evaluating the presence of CC lesions on brain MR scans can be used as a radiological sign for a differential diagnosis between MS and FD, rapidly addressing the physician toward a correct diagnosis and subsequent treatment options.
引用
- Cocozza S, Olivo G, Riccio E, et al. Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis. Neuroradiology. 2017. PMID: 28386689. doi:10.1007/s00234-017-1829-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。